4888.T JPX
Stella Pharma Corporation
1W: -0.5%
1M: +18.3%
3M: +37.0%
YTD: +23.8%
1Y: +5.7%
3Y: +32.3%
5Y: -25.9%
¥452.00 ($2.86)
+26.00 (+6.10%)
Weekly Expected Move ±6.2%
¥373
¥400
¥426
¥452
¥479
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$140M
+116.0% ▲
Capital Expenditures
$4M
+64.4% ▲
5Y CAGR: -37.6%
Free Cash Flow
$136M
+115.4% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$26K
+0.0% ▲
Net Change in Cash
$1.1B
+274.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$656M | -$764M | -$776M | -$761M | -$141M |
| Depreciation & Amort. | $31M | $34M | $35M | $35M | $35M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$143M | -$350M | -$85M | -$151M | $194M |
| Other Non-Cash Items | -$5M | -$1M | -$2M | -$293K | $52M |
| Operating Cash Flow | -$773M | -$1.1B | -$828M | -$877M | $140M |
| — Investing Activities — | |||||
| Capital Expenditures | -$22M | -$46M | -$29M | -$11M | -$12M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | -$305M | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$420K | $420K | -$596K | $2M | $300M |
| Investing Cash Flow | -$23M | -$351M | -$30M | -$9M | $288M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$160M | -$160M | -$160M | -$160M | -$216M |
| Stock Repurchased | $0 | $0 | -$30K | $0 | -$26K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$372M | $373M | $14M | $103K | -$5M |
| Financing Cash Flow | -$332M | $3.8B | $292M | $228M | $721M |
| Net Change in Cash | -$1.1B | $2.4B | -$566M | -$657M | $1.1B |
| Cash End of Period | $838M | $3.2B | $2.7B | $2.0B | $3.2B |
| Free Cash Flow | -$795M | -$1.1B | -$857M | -$888M | $136M |